BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

88 related articles for article (PubMed ID: 17510312)

  • 1. Assessment of methylation events during colorectal tumor progression by absolute quantitative analysis of methylated alleles.
    de Maat MF; Umetani N; Sunami E; Turner RR; Hoon DS
    Mol Cancer Res; 2007 May; 5(5):461-71. PubMed ID: 17510312
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Methylation of p16 and Ras association domain family protein 1a during colorectal malignant transformation.
    Umetani N; de Maat MF; Sunami E; Hiramatsu S; Martinez S; Hoon DS
    Mol Cancer Res; 2006 May; 4(5):303-9. PubMed ID: 16687485
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Quantitative analysis of methylation of genomic loci in early-stage rectal cancer predicts distant recurrence.
    de Maat MF; van de Velde CJ; van der Werff MP; Putter H; Umetani N; Klein-Kranenbarg EM; Turner RR; van Krieken JH; Bilchik A; Tollenaar RA; Hoon DS
    J Clin Oncol; 2008 May; 26(14):2327-35. PubMed ID: 18467724
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Use of DNA from human stools to detect aberrant CpG island methylation of genes implicated in colorectal cancer.
    Belshaw NJ; Elliott GO; Williams EA; Bradburn DM; Mills SJ; Mathers JC; Johnson IT
    Cancer Epidemiol Biomarkers Prev; 2004 Sep; 13(9):1495-501. PubMed ID: 15342451
    [TBL] [Abstract][Full Text] [Related]  

  • 5. CpG island methylation of genes accumulates during the adenoma progression step of the multistep pathogenesis of colorectal cancer.
    Kim YH; Petko Z; Dzieciatkowski S; Lin L; Ghiassi M; Stain S; Chapman WC; Washington MK; Willis J; Markowitz SD; Grady WM
    Genes Chromosomes Cancer; 2006 Aug; 45(8):781-9. PubMed ID: 16708352
    [TBL] [Abstract][Full Text] [Related]  

  • 6. N-Myc downstream-regulated gene 4 (NDRG4): a candidate tumor suppressor gene and potential biomarker for colorectal cancer.
    Melotte V; Lentjes MH; van den Bosch SM; Hellebrekers DM; de Hoon JP; Wouters KA; Daenen KL; Partouns-Hendriks IE; Stessels F; Louwagie J; Smits KM; Weijenberg MP; Sanduleanu S; Khalid-de Bakker CA; Oort FA; Meijer GA; Jonkers DM; Herman JG; de Bruïne AP; van Engeland M
    J Natl Cancer Inst; 2009 Jul; 101(13):916-27. PubMed ID: 19535783
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Formamide as a denaturant for bisulfite conversion of genomic DNA: Bisulfite sequencing of the GSTPi and RARbeta2 genes of 43 formalin-fixed paraffin-embedded prostate cancer specimens.
    Zon G; Barker MA; Kaur P; Groshen S; Jones LW; Imam SA; Boyd VL
    Anal Biochem; 2009 Sep; 392(2):117-25. PubMed ID: 19505431
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Decreased expression of repulsive guidance molecule member A by DNA methylation in colorectal cancer is related to tumor progression.
    Zhao ZW; Lian WJ; Chen GQ; Zhou HY; Wang GM; Cao X; Yang HJ; Hou YP
    Oncol Rep; 2012 May; 27(5):1653-9. PubMed ID: 22367090
    [TBL] [Abstract][Full Text] [Related]  

  • 9. MGMT germline polymorphism is associated with somatic MGMT promoter methylation and gene silencing in colorectal cancer.
    Ogino S; Hazra A; Tranah GJ; Kirkner GJ; Kawasaki T; Nosho K; Ohnishi M; Suemoto Y; Meyerhardt JA; Hunter DJ; Fuchs CS
    Carcinogenesis; 2007 Sep; 28(9):1985-90. PubMed ID: 17621591
    [TBL] [Abstract][Full Text] [Related]  

  • 10. PRDM5 identified as a target of epigenetic silencing in colorectal and gastric cancer.
    Watanabe Y; Toyota M; Kondo Y; Suzuki H; Imai T; Ohe-Toyota M; Maruyama R; Nojima M; Sasaki Y; Sekido Y; Hiratsuka H; Shinomura Y; Imai K; Itoh F; Tokino T
    Clin Cancer Res; 2007 Aug; 13(16):4786-94. PubMed ID: 17699856
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Methylation of the MGMT and p16 genes in sporadic colorectal carcinoma and corresponding normal colonic mucosa.
    Krakowczyk L; Strzelczyk JK; Adamek B; Zalewska-Ziob M; Arendt J; Półtorak S; Maciejewski B; Wiczkowski A
    Med Sci Monit; 2008 Oct; 14(10):BR219-25. PubMed ID: 18830187
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Variable DNA methylation patterns associated with progression of disease in hepatocellular carcinomas.
    Gao W; Kondo Y; Shen L; Shimizu Y; Sano T; Yamao K; Natsume A; Goto Y; Ito M; Murakami H; Osada H; Zhang J; Issa JP; Sekido Y
    Carcinogenesis; 2008 Oct; 29(10):1901-10. PubMed ID: 18632756
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Real-time PCR-based assay for quantitative determination of methylation status.
    Lehmann U; Kreipe H
    Methods Mol Biol; 2004; 287():207-18. PubMed ID: 15273414
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The relationship between gene-specific DNA methylation in leukocytes and normal colorectal mucosa in subjects with and without colorectal tumors.
    Ally MS; Al-Ghnaniem R; Pufulete M
    Cancer Epidemiol Biomarkers Prev; 2009 Mar; 18(3):922-8. PubMed ID: 19258481
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Identification and validation of colorectal neoplasia-specific methylation markers for accurate classification of disease.
    Model F; Osborn N; Ahlquist D; Gruetzmann R; Molnar B; Sipos F; Galamb O; Pilarsky C; Saeger HD; Tulassay Z; Hale K; Mooney S; Lograsso J; Adorjan P; Lesche R; Dessauer A; Kleiber J; Porstmann B; Sledziewski A; Lofton-Day C
    Mol Cancer Res; 2007 Feb; 5(2):153-63. PubMed ID: 17314273
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hypermethylation status of APC inversely correlates with the presence of submucosal invasion in laterally spreading colorectal tumors.
    Hashimoto K; Shimizu Y; Suehiro Y; Okayama N; Hashimoto S; Okada T; Hiura M; Ueno K; Hazama S; Higaki S; Hamanaka Y; Oka M; Sakaida I; Hinoda Y
    Mol Carcinog; 2008 Jan; 47(1):1-8. PubMed ID: 17620311
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Quantification of methylation of SNCG CpG islands in human tissue samples by the combined COBRA-DHPLC assay].
    Zhou J; Wen XZ; Deng DJ
    Zhonghua Yu Fang Yi Xue Za Zhi; 2007 Jun; 41 Suppl():20-4. PubMed ID: 17767852
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Aberrant methylation of the UNC5C gene is frequently detected in advanced colorectal cancer.
    Hibi K; Mizukami H; Shirahata A; Goto T; Sakata M; Saito M; Ishibashi K; Kigawa G; Nemoto H; Sanada Y
    Anticancer Res; 2009 Jan; 29(1):271-3. PubMed ID: 19331160
    [TBL] [Abstract][Full Text] [Related]  

  • 19. GATA4 and GATA5 are potential tumor suppressors and biomarkers in colorectal cancer.
    Hellebrekers DM; Lentjes MH; van den Bosch SM; Melotte V; Wouters KA; Daenen KL; Smits KM; Akiyama Y; Yuasa Y; Sanduleanu S; Khalid-de Bakker CA; Jonkers D; Weijenberg MP; Louwagie J; van Criekinge W; Carvalho B; Meijer GA; Baylin SB; Herman JG; de Bruïne AP; van Engeland M
    Clin Cancer Res; 2009 Jun; 15(12):3990-7. PubMed ID: 19509152
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Aberrant methylation of APC, MGMT, RASSF2A, and Wif-1 genes in plasma as a biomarker for early detection of colorectal cancer.
    Lee BB; Lee EJ; Jung EH; Chun HK; Chang DK; Song SY; Park J; Kim DH
    Clin Cancer Res; 2009 Oct; 15(19):6185-91. PubMed ID: 19773381
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.